ThinkGenetic, Inc.

04/24/2024

Kicking off the first full day at the World Orphan Drug Congress in Boston, where collaboration takes center stage. From patient advocacy to legislative discussions and AI advancements, diverse topics are fueling engaging conversations on all the main stages today.

03/26/2024

Today we unveil more insights from a recent interview with Dawn Laney, MS, CGC, CCRC, our Chief Genetic Officer. In this enlightening discussion, Dawn delves into the exciting use of AI at ThinkGenetic, Inc. to expedite the uncovering of at-risk patients for an underlying rare or genetic condition. By leveraging artificial intelligence alongside the expertise of genetic counselors, we've developed an innovative model and are taking on more projects every day. Watch to learn more about our approach and commitment to transforming healthcare.

03/06/2024

Interested in hearing about the journey behind ThinkGenetic Inc.'s mission to accelerate rare disease diagnosis? Tune in to this recent audio interview with Kristina Inman on the Grey Genetics Patient Stories Podcast as she speaks with our founder, Dave Jacob.

🔗 Link to the audio interview: https://loom.ly/KvytP3g

In this insightful conversation, Dave delves into his late diagnosis of Cutis Laxa, a rare genetic disorder, and the pivotal moments that inspired him to create ThinkGenetic. From navigating his health challenges to witnessing his sister's journey, Dave's experience underscores the urgency and importance of efficient and accurate diagnosis for all rare disease patients worldwide. Fueled by a passion for innovation and a commitment to making a difference, Dave teamed up with his daughter, Dawn Laney, a renowned genetic counselor, and Len Barker, to establish ThinkGenetic, Inc. with a mission to combine clinical expertise and technology to accelerate the detection of at-risk patients for evaluation, testing, treatment, and clinical trials for rare diseases.

You'll also gain firsthand insights into the core driver of ThinkGenetic's work and the relentless pursuit of a world where rare disease diagnosis is swift and precise.

A Late Diagnosis of Cutis Laxa and the Creation of ThinkGenetics Dave and one of his younger sisters were both born with heart defects that required surgery. When Dave was 60, he was diagnosed with an aortic aneurysm. By this time, he had a daughter, Dawn Laney, who was a genetic counselor and profe...

02/29/2024

Join us in honoring Rare Disease Day 2024 with an insightful reflection on the challenges and triumphs faced by millions worldwide. In this article, Michael Bray, PhD, MS, CGC, Clinical Genetic Data Specialist at ThinkGenetic, Inc., shares profound insights into the journey of those living with rare diseases and our unwavering commitment to accelerate change. Discover how we're working tirelessly to shorten the diagnostic odyssey.

Join us in reflecting on Rare Disease Day 2024 as Michael Bray, PhD, MS, CGC, Clinical Genetic Data Specialist, shares insights into the challenges faced by those with rare diseases and our commitment at ThinkGenetic, Inc. to shorten the diagnostic journey. Explore our collaborative efforts to raise...

02/23/2024

Next week is Rare Disease Day. Are you ready?

This official international awareness-raising campaign happens annually on the last day of February. The focus is to increase awareness among the general public and decision-makers about rare diseases and their influence on the lives of families living with these conditions. With over 300 million people globally living with a rare disease let's come together to advocate for equitable access to diagnosis, treatment, care, and social opportunities.

Not sure where to start? Information, resources, and events schedules are available now at https://loom.ly/EYnCzEg. Rare Disease Day MassBio Rare New England ThinkGenetic, Inc.

02/07/2024

02/06/2024

ThinkGenetic, Inc. leaders, Ruth Jacob O’Keefe and Dawn Laney are thrilled to be part of the in San Diego this week. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

01/18/2024

Today, our CEO, Ruth Jacob O'Keefe, shared a short reflection on the past year at ThinkGenetic, expressing gratitude to our dedicated community for their unwavering commitment. She emphasized our mission to combine clinical expertise and AI to accelerate the detection of at-risk patients for evaluation, treatment, and clinical trials for rare diseases.

Dive deeper into her insights and our vision for 2024 in her open letter: https://loom.ly/9c57x8U

01/17/2024

ThinkGenetic is pleased to announce the participation of its new Chief Executive Officer, Ruth Jacob O'Keefe, alongside Chief Genetic Officer, Dawn Laney at the upcoming 20th Annual WORLDSymposium™.

The WORLDSymposium Annual Scientific Meeting stands as a pivotal research conference dedicated to lysosomal diseases. Aligned with ThinkGenetic, Inc. mission to integrate clinical expertise and AI for the expedited detection of at-risk patients for clinical evaluation, treatment, and clinical trials for rare diseases, the WORLDSymposium remains a steadfast event for ThinkGenetic and its partners.

We invite you to explore opportunities for connection with our leadership team at the WORLDSymposium. To schedule a meeting with a ThinkGenetic, Inc. team member, please visit https://lnkd.in/eJjc3WAs

12/13/2023

ThinkGenetic is excited to welcome new Clinical Genetic Data Specialist, Michael Bray, MS, PhD, CGC to the clinical team.

Michael has over a decade of experience in genetic research with an emphasis on performing genetic analyses on data involving biobank repositories linked to de-identified electronic health records. More recently, Michael became a genetic counselor returning genetic test results to patients at risk for genetic diseases. Michael’s passion includes discovering new information involving human genetics and sharing that knowledge with others.

At ThinkGenetic, Michael curates and fine-tunes phenotyping algorithms to find undiagnosed individuals at risk for rare genetic conditions.